- Home
- CLDX vs CGBD Comparison
CLDX vs CGBD Comparison
Compare CLDX & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- CGBD
- Stock Information
- Founded
- CLDX N/A
- CGBD 2012
- Country
- CLDX United States
- CGBD United States
- Employees
- CLDX N/A
- CGBD N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CGBD Finance: Consumer Services
- Sector
- CLDX Health Care
- CGBD Finance
- Exchange
- CLDX Nasdaq
- CGBD Nasdaq
- Market Cap
- CLDX 1.3B
- CGBD 1.0B
- IPO Year
- CLDX 2008
- CGBD 2017
- Fundamental
- Price
- CLDX $20.10
- CGBD $14.09
- Analyst Decision
- CLDX Buy
- CGBD Hold
- Analyst Count
- CLDX 9
- CGBD 3
- Target Price
- CLDX $50.00
- CGBD $14.00
- AVG Volume (30 Days)
- CLDX 664.5K
- CGBD 424.7K
- Earning Date
- CLDX 05-08-2025
- CGBD 05-06-2025
- Dividend Yield
- CLDX N/A
- CGBD 12.53%
- EPS Growth
- CLDX N/A
- CGBD N/A
- EPS
- CLDX N/A
- CGBD 1.30
- Revenue
- CLDX $7,559,000.00
- CGBD $225,447,000.00
- Revenue This Year
- CLDX N/A
- CGBD $12.25
- Revenue Next Year
- CLDX N/A
- CGBD $0.49
- P/E Ratio
- CLDX N/A
- CGBD $10.68
- Revenue Growth
- CLDX 24.49
- CGBD N/A
- 52 Week Low
- CLDX $14.40
- CGBD $13.12
- 52 Week High
- CLDX $47.00
- CGBD $18.74
- Technical
- Relative Strength Index (RSI)
- CLDX 53.76
- CGBD 43.74
- Support Level
- CLDX $18.47
- CGBD $13.83
- Resistance Level
- CLDX $20.42
- CGBD $14.39
- Average True Range (ATR)
- CLDX 1.29
- CGBD 0.42
- MACD
- CLDX -0.02
- CGBD 0.04
- Stochastic Oscillator
- CLDX 60.32
- CGBD 42.08
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.